Primary progressive aphasia-defining genetic and pathological subtypes

Current Alzheimer Research

Volumn 8, Issue 3, 2011, Pages 266-272

  Rohrer, J D ^a   Schott, J M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Frontotemporal lobar degeneration; Frontotemporaldementia; Logopenic aphasia; Primary progressive aphasia; Progranulin; Progressive nonfluent aphasia; Semantic dementia; Tau; TDP 43

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; PITTSBURGH COMPOUND B; PROGRANULIN; TAR DNA BINDING PROTEIN; TAU PROTEIN;

CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE MUTATION; HUMAN; MUTATIONAL ANALYSIS; NEUROPATHOLOGY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SEMANTIC DEMENTIA;

APHASIA, PRIMARY PROGRESSIVE; BIOLOGICAL MARKERS; DNA-BINDING PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; TAU PROTEINS;

EID: 79956265831     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720511795563728     Document Type: Review

References (84)

1. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 11(6): 592-8 (1982).
2. Mesulam MM. Primary progressive aphasia. Ann Neurol 49(4): 425-32 (2001).
3. Mesulam MM. Primary progressive aphasia--a language-based dementia. N Engl J Med 349(16): 1535-42 (2003).
4. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55(3): 335-46 (2004).
5. Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, etal. Clinicopathological correlates in frontotemporal dementia. AnnNeurol 56(3): 399-406 (2004).
6. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, ParisiJE, et al. Clinicopathological and imaging correlates of progressiveaphasia and apraxia of speech. Brain 129(Pt 6): 1385-98 (2006).
7. Mesulam M, Wicklund A, Johnson N, Rogalski E, Léger GC, Rademaker A, et al. Alzheimer and frontotemporal pathology insubsets of primary progressive aphasia. Ann Neurol 63(6): 709-719(2008).
8. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, etal. Frontotemporal lobar degeneration: a consensus on clinical diagnosticcriteria. Neurology 51: 1546-54 (1998).
9. Rascovsky K, Hodges JR, Kipps CM, Johnson JK, Seeley WW,Mendez MF, et al. Diagnostic criteria for the behavioral variant offrontotemporal dementia (bvFTD): current limitations and futuredirections. Alzheimer Dis Assoc Disord 21(4): S14-8 (2007).
10. Graham NL, Bak T, Patterson K, Hodges JR. Language functionand dysfunction in corticobasal degeneration. Neurology 61(4):493-9 (2003).
11. da Rocha AJ, Valério BC, Buainain RP, Ferraz ME, da Silva CJ, Maia AC Jr, et al. Motor neuron disease associated with non-fluentrapidly progressive aphasia: case report and review of the literature.Eur J Neurol 14(9): 971-5 (2007).
12. Warrington EK. The selective impairment of semantic memory. QJ Exp Psychol 27: 635-657 (1975).
13. Snowden JS, Goulding PJ, Neary D. Semantic dementia: a form ofcircumscribed cerebral atrophy. Behav Neurol 2: 167-182 (1989).
14. Adlam AL, Patterson K, Rogers TT, Nestor PJ, Salmond CH,Acosta-Cabronero J, et al. Semantic dementia and fluent primaryprogressive aphasia: two sides of the same coin? Brain 129: 3066-80 (2006).
15. Knopman DS, Kramer JH, Boeve BF, Caselli RJ, Graff-RadfordNR, Mendez MF, et al. Development of methodology for conductingclinical trials in frontotemporal lobar degeneration. Brain 131(Pt 11): 2957-68 (2008).
16. Rohrer JD, Ridgway GR, Crutch SJ, Hailstone J, Goll JC, ClarksonMJ, et al. Progressive logopenic/phonological aphasia: erosion ofthe language network. Neuroimage 49(1): 984-9 (2010).
17. Gorno-Tempini ML, Brambati SM, Ginex V, Ogar J, Dronkers NF,Marcone A, et al. The logopenic/phonological variant of primaryprogressive aphasia. Neurology 71(16): 1227-34 (2008).
18. Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, Kerdraon O, et al. Prediction of pathology in primaryprogressive language and speech disorders. Neurology 74(1): 42-49(2010).
19. Rohrer JD, Fox NC. Neuroimaging of Primary Progressive Aphasia.Euro Neurol J 1(1): (2009).
20. Kertesz A, Davidson W, McCabe P, Takagi K, Munoz D. Primaryprogressive aphasia: diagnosis, varieties, evolution. J Int NeuropsycholSoc 9(5): 710-9 (2003).
21. Rohrer JD, Crutch SJ, Warrington EK, Warren JD. Progranulinassociatedprimary progressive aphasia: a distinct phenotype? Neuropsychologia48(1): 288-97 (2010).
22. Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, HatanpaaKJ, et al. Neuropathologic diagnostic and nosologic criteriafor frontotemporal lobar degeneration: consensus of the Consortiumfor Frontotemporal Lobar Degeneration. Acta Neuropathol(Berl) 114: 5-22 (2007).
23. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, KrilJ, et al. Nomenclature and nosology for neuropathologic subtypesof frontotemporal lobar degeneration: an update. Acta Neuropathol119(1): 1-4 (2010).
24. Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration:clinical and pathological relationships. Acta Neuropathol 114(1):31-8 (2007).
25. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA,Mackenzie IR. A new subtype of frontotemporal lobar degenerationwith FUS pathology. Brain 132(Pt 11): 2922-31 (2009).
26. Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, AdamsonJL, et al. Progranulin mutations in primary progressive aphasia:the PPA1 and PPA3 families. Arch Neurol 64(1): 43-7 (2007).
27. Snowden JS, Pickering-Brown SM, Du Plessis D, Mackenzie IR,Varma A, Mann DM, et al. Progressive anomia revisited: focal degenerationassociated with progranulin gene mutation. Neurocase13(5): 366-77 (2007).
28. Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, et al. Phenotype variability in progranulin mutation carriers:a clinical, neuropsychological, imaging and genetic study.Brain 131(Pt 3): 732-46 (2008).
29. Janssen JC, Schott JM, Cipolotti L, Fox NC, Scahill RI, JosephsKA, et al. Mapping the onset and progression of atrophy in familialfrontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry76(2): 162-8 (2005).
30. Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, et al. The heritability and genetics of frontotemporal lobar degeneration.Neurology 73(18): 1451-6 (2009).
31. Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, Richardson AM, et al. Frequency and clinical characteristicsof progranulin mutation carriers in the Manchester frontotemporallobar degeneration cohort: comparison with patients withMAPT and no known mutations. Brain 131(Pt 3): 721-31 (2008).
32. Rohrer JD, Ridgway GR, Modat M, Ourselin S, Mead S, Fox NC,et al. Distinct profiles of brain atrophy in frontotemporal lobar degenerationcaused by progranulin and tau mutations. Neuroimage53(3): 1070-6 (2010).
33. Munoz DG, Ros R, Fatas M, Bermejo F, de Yebenes JG.Progressive nonfluent aphasia associated with a new mutationV363I in tau gene. Am J Alzheimers Dis Other Demen 22(4): 294-9 (2007).
34. Godbolt AK, Beck JA, Collinge J, Garrard P, Warren JD, Fox NC, et al. A presenilin 1 R278I mutation presenting with language impairment.Neurology 63(9): 1702-4 (2004).
35. Rossor MN, Revesz T, Lantos PL, Warrington EK. Semantic dementiawith ubiquitin-positive tau-negative inclusion bodies. Brain123 (Pt 2): 267-76 (2000).
36. Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, XuerebJH. The pathological basis of semantic dementia. Brain 128: 1984-1995 (2005).
37. Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathologicalcharacterization of progressive aphasia. Ann Neurol 59(1):156-165 (2006).
38. Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH,McMonagle P, et al. Semantic dementia: demography, familial factorsand survival in a consecutive series of 100 cases. Brain 133(Pt1): 300-6 (2010).
39. Shi J, Shaw CL, Du Plessis D, Richardson AM, Bailey KL, JulienC, et al. Histopathological changes underlying frontotemporal lobardegeneration with clinicopathological correlation. Acta Neuropathol.110(5): 501-12 (2005).
40. Rohrer JD, Warren JD, Modat M, Ridgway GR, Douiri A, Rossor MN, et al. Patterns of cortical thinning in the language variants offrontotemporal lobar degeneration. Neurology 72(18): 1562-1569(2009).
41. Paviour DC, Lees AJ, Josephs KA, Ozawa T, Ganguly M, StrandC, et al. Frontotemporal lobar degeneration with ubiquitin-onlyimmunoreactiveneuronal changes: broadening the clinical pictureto include progressive supranuclear palsy. Brain 127(Pt 11): 2441-51 (2004).
42. Rohrer JD, Paviour D, Bronstein AM, O'Sullivan SS, Lees A, WarrenJD. Progressive supranuclear palsy syndrome presenting asprogressive nonfluent aphasia: A neuropsychological and neuroimaginganalysis. Mov Disord 25(2): 179-88 (2010).
43. Davion S, Johnson N, Weintraub S, Mesulam MM, Engberg A,Mishra M, et al. Clinicopathologic correlation in PGRN mutations.Neurology 69(11): 1113-21 (2007).
44. Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, et al. A distinct clinical, neuropsychological and radiologicalphenotype is associated with progranulin gene mutations in a largeUK series. Brain 131(Pt 3): 706-20 (2008).
45. Josephs KA, Duffy JR. Apraxia of speech and nonfluent aphasia: anew clinical marker for corticobasal degeneration and progressivesupranuclear palsy. Curr Opin Neurol 21(6): 688-92 (2008).
46. Rohrer JD, Rossor MN, Warren JD. Apraxia in progressive nonfluentaphasia. J Neurol 257(4): 569-74 (2010).
47. Rascovsky K, Salmon DP, Ho GJ, Galasko D, Peavy GM, HansenLA, et al. Cognitive profiles differ in autopsy-confirmed frontotemporaldementia and AD. Neurology 58(12): 1801-8 (2002).
48. Grossman M, Libon DJ, Forman MS, Massimo L, Wood E, Moore P, et al. Distinct antemortem profiles in patients with pathologicallydefined frontotemporal dementia. Arch Neurol 64(11): 1601-1609(2007).
49. Josephs KA, Whitwell JL, Duffy JR, Vanvoorst WA, Strand EA, Hu WT, et al. Progressive aphasia secondary to Alzheimer diseasevs FTLD pathology. Neurology 70(1): 25-34 (2008).
50. Wilson SM, Ogar JM, Laluz V, Growdon M, Jang J, Glenn S, et al.Automated MRI-based classification of primary progressive aphasiavariants. Neuroimage 47(4): 1558-67 (2009).
51. Pereira JM, Williams GB, Acosta-Cabronero J, Pengas G, SpillantiniMG, Xuereb JH, et al. Atrophy patterns in histologic vsclinical groupings of frontotemporal lobar degeneration. Neurology72(19): 1653-60 (2009).
52. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. Abeta amyloid and glucose metabolism in threevariants of primary progressive aphasia. Ann Neurol 64(4): 388-401 (2008).
53. Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, et al. Imaging of amyloid beta in Alzheimer's disease with 18FBAY94-9172, a novel PET tracer: proof of mechanism. LancetNeurol 7(2): 129-35 (2008).
54. Coppola G, Karydas A, Rademakers R, Wang Q, Baker M, Hutton M, et al. Gene expression study on peripheral blood identifies progranulinmutations. Ann Neurol 64(1): 92-6 (2008).
55. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, et al. Plasma progranulin levels predict progranulin mutation status infrontotemporal dementia patients and asymptomatic family members.Brain 132(Pt 3): 583-91 (2009).
56. Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G. Lowplasma progranulin levels predict progranulin mutations in frontotemporallobar degeneration. Neurology 71(16): 1235-9 (2008).
57. Foulds P, McAuley E, Gibbons L, Davidson Y, Pickering-Brown SM, Neary D, et al. TDP-43 protein in plasma may index TDP-43brain pathology in Alzheimer's disease and frontotemporal lobardegeneration. Acta Neuropathol 116(2): 141-6 (2008).
58. Foulds PG, Davidson Y, Mishra M, Hobson DJ, Humphreys KM, Taylor M, et al. Plasma phosphorylated-TDP-43 protein levels correlatewith brain pathology in frontotemporal lobar degeneration.Acta Neuropathol 118(5): 547-58 (2009)[59] Bian H, Van Swieten JC, Leight S, Massimo L, Wood E, FormanM, et al. CSF biomarkers in frontotemporal lobar degenerationwith known pathology. Neurology 70(19 Pt 2): 1827-35 (2008).
59. Bian H, Van Swieten JC, Leight S, Massimo L, Wood E, FormanM, et al. CSF biomarkers in frontotemporal lobar degenerationwith known pathology. Neurology 70(19 Pt 2): 1827-35 (2008).
60. Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, et al. Cerebrospinal fluid {beta}-amyloid 42 and tauproteins as biomarkers of Alzheimer-type pathologic changes in thebrain. Arch Neurol 66(3): 382-9 (2009).
61. Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engelborghs S. Improved discrimination of autopsy-confirmedAlzheimer's disease (AD) from non-AD dementias using CSF Ptau(181P). Neurochem Int 55(4): 214-8 (2009).
62. Borroni B, Gardoni F, Parnetti L, Magno L, Malinverno M, Saggese E, et al. Pattern of Tau forms in CSF is altered in progressivesupranuclear palsy. Neurobiol Aging 30(1): 34-40 (2009).
63. Borroni B, Malinverno M, Gardoni F, Alberici A, Parnetti L, Premi E, et al. Tau forms in CSF as a reliable biomarker for progressivesupranuclear palsy. Neurology 71(22): 1796-803 (2008).
64. Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CA, Lehnert S, et al. TDP-43 in cerebrospinal fluid of patients withfrontotemporal lobar degeneration and amyotrophic lateral sclerosis.Arch Neurol 65(11): 1481-7 (2008).
65. Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, et al. Increased TDP-43 protein in cerebrospinal fluid of patientswith amyotrophic lateral sclerosis. Acta Neuropathol 117(1):55-62 (2009).
66. Wakabayashi K, Shibasaki Y, Hasegawa M, Horikawa Y, Soma Y, Hayashi S, et al. Primary progressive aphasia with focal glialtauopathy. Neuropathol Appl Neurobiol 26: 477-481 (2000).
67. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typicalpresentations of Alzheimer's disease: a clinical, neuropsychological,neuroimaging and pathological study of 13 cases. Brain 123 Pt 3: 484-98 (2000).
68. Li F, Iseki E, Kato M, Adachi Y, Akagi M, Kosaka K. An autopsycase of Alzheimer's disease presenting with primary progressiveaphasia: a clinicopathological and immunohistochemical study.Neuropathology 20(3): 239-45 (2000).
69. Mimura M, Oda T, Tsuchiya K, Kato M, Ikeda K, Hori K, et al.Corticobasal degeneration presenting with nonfluent primary progressiveaphasia: a clinicopathological study. J Neurol Sci 183(1):19-26 (2001).
70. Mochizuki A, Ueda Y, Komatsuzaki Y, Tsuchiya K, Arai T, ShojiS. Progressive supranuclear palsy presenting with primary progressiveaphasia--clinicopathological report of an autopsy case. ActaNeuropathol 105(6): 610-4 (2003).
71. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and itsrelationship to progressive supranuclear palsy and frontotemporaldementia. Ann Neurol 54: S15-S19 (2003).
72. Ferrer I, Hernández I, Boada M, Llorente A, Rey MJ, Cardozo A, et al. Primary progressive aphasia as the initial manifestation ofcorticobasal degeneration and unusual tauopathies. Acta Neuropatho l106(5): 419-35 (2003).
73. Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ, et al. Antemortem diagnosis of frontotemporal lobar degeneration.Ann Neurol 57(4): 480-8 (2005).
74. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. Theevolution and pathology of frontotemporal dementia. Brain 128(Pt9): 1996-2005 (2005).
75. Karnik NS, D'Apuzzo M, Greicius M. Non-Fluent ProgressiveAphasia, Depression, and OCD in a Woman With Progressive SupranuclearPalsy: Neuroanatomical and Neuropathological Correlations.Neurocase 12: 332-338 (2006).
76. Josephs KA, Boeve BF, Duffy JR, Smith GE, Knopman DS, Parisi JE, et al. Atypical progressive supranuclear palsy underlying progressiveapraxia of speech and nonfluent aphasia. Neurocase 11:283-296 (2005).
77. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal andcorticobasal degenerations and PSP. Neurology 66(1): 41-48(2006b).
78. Sánchez-Valle R, Forman MS, Miller BL, Gorno-Tempini ML.From progressive nonfluent aphasia to corticobasal syndrome: acase report of corticobasal degeneration. Neurocase 12(6): 355-359(2006).
79. Takao M, Tsuchiya K, Mimura M, Momoshima S, Kondo H, AkiyamaH, et al. Corticobasal degeneration as cause of progressivenon-fluent aphasia: clinical, radiological and pathological study ofan autopsy case. Neuropathology 26(6): 569-78 (2006).
80. Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, et al.Focal cortical presentations of Alzheimer's disease. Brain 130(Pt10): 2636-45 (2007).
81. Gerstner E, Lazar RM, Keller C, Honig LS, Lazar GS, Marshall RS, A case of progressive apraxia of speech in pathologically verifiedAlzheimer disease. Cogn Behav Neurol 20(1): 15-20 (2007).
82. Lladó A, Sánchez-Valle R, Rey MJ, Ezquerra M, Tolosa E, Ferrer I, et al. Clinicopathological and genetic correlates of frontotemporallobar degeneration and corticobasal degeneration. J Neuro l255(4): 488-94 (2008).
83. Tree JJ, Kay J. Longitudinal assessment of language and memoryimpairments in pathologically confirmed cortico-basal ganglionicdegeneration. Cortex 44(9): 1234-1244 (2008).
84. Chow TW, Varpetian A, Moss T, Vinters HV, Marquez S, Miller C. Alzheimer's disease neuropathologic changes in semantic dementia. Neurocase 16(1): 15-22 (2010).